XENETIC BIOSCIENCES, INC. Contractual Obligation
XENETIC BIOSCIENCES, INC. (XBIO) had Contractual Obligation of $1.00 thousand as of 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Notes › Commitment and Contingencies
us-gaap:ContractualObligation · last filed 2017-11-14
- 2017-09-30: Contractual Obligation $1.00K.
- 2017-06-30: Contractual Obligation $6.00K.
- 2017-03-31: Contractual Obligation $9.97K.
| Period end | Contractual Obligation |
|---|---|
| 2017-09-30 | $1.00K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $6.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $9.97K 10-Q · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |